Arthritis and primary biliary cirrhosis Articular problems are more commonly associated with active chronic hepatitis, viral hepatitis, and haemochromatosis,l than with primary biliary "cirrhosis" (PBC; chronic, non-suppurative, destructive cholangitis).2 Of 12 patients with PBC seen in this hospital over the past three years, however, five had appreciable arthritic lesions and circulating rheumatoid factor. We wish to emphasise the frequency of this association by reporting details of these patients. Case 5-A 49-year-old woman developed pruritus after cholecystectomy. An operative liver biopsy specimen showed the histological appearances of PBC. Jaundice, hypercholesterolaemia (maximum serum cholesterol concentration 24 mmol/l (927 mg/ 100 ml)), and hepatosplenomegaly developed, as did a non-erosive anodular arthritis affecting the hands, wrists, shoulders and one knee.
Comment
Arthralgia or rheumatoid arthritis are thought to occur only rarely in patients with PBC, although circulating rheumatoid factor may be detected in a quarter of such patients.4 Thus articular symptoms were recorded in four per cent of 47 patients in one series2 and "rheumatoid arthritis" in five per cent of 100 patients in another. 3 The severity of the arthritic symptoms of the five patients we described and the histological evidence for PBC varied, the two aspects being generally inversely related. Serological results were positive for rheumatoid factor in all patients (see table) , and patients 1 and 2 fulfilled the American Rheumatism Association's criteria for "definite" rheumatoid arthritis. Patient 1 had severe systemic involvement compatible with rheumatoid disease, and articular erosions and nodules; lesser erosive changes were present in patients 2 and 3. Only patient 5 had hypercholesterolaemia, and although the joint -fluid from this patient contained free cholesterol crystals, crystals from a needle synovial biopsy were too minute to identify. A similar biopsy finding was obtained from patient 4, in whose joint fluid no crystals were detected. The relation of crystals to joint symptoms is not clear.
There were periportal granulomatous changes in the liver biopsy specimens from patients 3 and 5, and that from patient 4 showed abnormal proliferating bile ductules. The specimens from patients 1 and 2, however, were only suggestive of PBC, their appearances being similar to those described in a series of patients having "autoimmune hepatitis" and circulating antimitochondrial antibodies but without overt liver disease.5 In patients 1 and 2 the greatly raised levels of Results of Rose-Waaler (sheep-cell agglutination) tests, x-ray appearances of joints, presence or absence of antimitochondrial antibody and antinuclear factor, and maximuiim serzm alkaline phosphatase concentrations in five patients with primary biliary cirrhosis and arthritis The effect of disodium cromoglycate (DSCG) on virus-cell interactions has not been extensively investigated. We therefore studied the effects of DSCG on in-vitro cell cultures, in in-vitro and in-vivo antiviral test systems, and on virus neutralisation by serum antibodies.
Methods and results
We examined the in-vitro cellular toxicity of DSCG by four different methods: (1) morphological changes induced in a monolayer of HEp2 cells incubated in tissue culture for not less than two days (human cell line); (2) inhibition of migration of guinea pig macrophages (primary mammalian); (3) morphological changes induced in chick embryo fibroblast cells (primary avian) in monolayer culture during three days' exposure to the compound; (4) alteration of ciliary activity of human bronchial tissue (human primary explant), measured on a highspeed camera.
For methods 1, 2, and 3 the cells were examined after exposure to different concentrations of DSCG (range 0-9-76 mmol/l (0-5 mg/ml)), but in each case the only dose showing toxicity was 9 76 mmol/l. Human ciliated tissue was not exposed to concentrations greater than 1-95 mmol/l (1 mg/ml). No toxic effects on ciliary frequency were observed. We also examined the effects of DSCG on virus-cell systems (see table). In the vaccinia, herpes, and polio systems, plaque assays were used to assess infectivity, while haemagglutination and haemadsorption was used to identify growth of virus for influenza and parainfluenza, and cytopathic effect for respiratory syncytial virus. DSCG was not found to have any activity in any of these systems up to the level at which toxicity in the cells was observed (9 76 mmol/l).
The effects of DSCG on viral antigen-antibody neutralisation reactions were studied in the following systems: human antiserum and-influenza A/PR/8, herpes, and polio viruses; rabbit antiserum and influenza A/PR/8, parainfluenza (Sendai), vaccinia, and polio viruses; and ferret antiserum and influenza A/HK virus. We used the assay systems referred to above, but no measurable effect of DSCG on virus-neutralising titre of the serum anti-
